Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Terminated 3Completed 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Sarcoma 1CNS 1

Conditions

Small Cell Lung Carcinoma 2Gliosarcoma 1Glioblastoma 1

Interventions

Cyclophosphamide 98pembrolizumab 85Gemcitabine 81Carboplatin 62fludarabine 61Nivolumab 57Cisplatin 54Paclitaxel 51Radiotherapy 50Docetaxel 49Rituximab 46Dexamethasone 42Lenalidomide 41Ipilimumab 38Azacitidine 35Etoposide 34Cytarabine 33Temozolomide 32Bevacizumab 32Radiation 29venetoclax 28Bortezomib 27Magnetic Resonance Spectroscopy 26Irinotecan 26Pemetrexed 25atezolizumab 24Oxaliplatin 24Capecitabine 24fludarabine phosphate 22Filgrastim 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Terminated × Chloroquine × Clear all
NCT04397679 2025-01-15

Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma

Barbara Ann Karmanos Cancer Institute

Phase 1 Terminated
2 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT00969306 2019-02-15

Chloroquine IV

Maastricht Radiation Oncology

Phase 1 Terminated
5 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01575782 2017-07-18

Chloroquine

Maastricht Radiation Oncology

Phase 1 Terminated
5 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡